Page 2 - Sofinnova Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.

/PRNewswire/ -- Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by...

/PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the appointment of...

Neurana Pharmaceuticals to Present at 21st Annual Pain Therapeutics Conference News provided by Share this article Share this article SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21 st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11 th.  Presentations will be available for registered attendees via the conference website. About Neurana Pharmaceuticals, Inc.  Neurana Pharmaceuticals...

(0) Novel mucoadhesive patch adheres to wet tissue surfaces and enables targeted, localized delivery of therapeutic to lesions inside the mouth AFYX Therapeutics ("AFYX"), a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced that a study of the Rivelin Clobetasol patch ("Rivelin-CLO"), a novel adhesive patch technology designed to deliver a therapeutic agent to wet tissue surfaces, was featured in the March issue of The European Journal of Oral Sciences. This is the first study to show the successful transmucosal delivery...